Physician profile
Elsayed Mohamed
NPI 1841484813
$14,707.62
in general payments reported to CMS, 2019-2025
20 companies · $1,747 in 2025
The $1,747 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,178 · 2020: $258 · 2021: $763 · 2022: $685 · 2023: $4,711 · 2024: $2,365 · 2025: $1,747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,500 · Food and Beverage: $3,241 · Travel and Lodging: $2,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,500.00 |
| Food and Beverage | $3,240.94 |
| Travel and Lodging | $2,082.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,190.14 | 2019-2025 | Evoque, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Bard Peripheral Vascular, INC. | $3,910.83 | 2023-2024 | Rotarexs 6 F X 135 Cm, Venovo |
| Abbott Laboratories | $2,403.76 | 2019-2025 | Ensite, Mitraclip, Cardiomems |
| Boston Scientific Corporation | $1,834.52 | 2019-2025 | Watchman Flx, Watchman Access System |
| Medtronic Vascular, INC. | $1,273.72 | 2019 | |
| Endologix LLC | $313.09 | 2022 | |
| Abiomed | $180.00 | 2023-2025 | Impella |
| Cardinal Health 200 LLC | $101.38 | 2019 | |
| Novartis Pharmaceuticals Corporation | $100.82 | 2019-2023 | |
| Gilead Sciences, INC. | $72.20 | 2025 | Yescarta |
| W. L. Gore & Associates, INC. | $69.23 | 2021-2024 | Gore Cardioform Septal Occluder |
| Stryker Corporation | $65.48 | 2025 | Clottriever Bold Catheter |
| Biotronik INC. | $51.60 | 2024-2025 | Orsiro Mission |
| Chiesi USA, INC. | $28.89 | 2020-2021 | |
| Cleerly, INC. | $26.74 | 2025 | Cleerly Ischemia, Cleerly Labs |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veryan Medical Incorporated | $21.15 | 2021 | |
| Teleflex LLC | $17.09 | 2025 | Manta |
| Livanova USA, INC. | $16.85 | 2021 | |
| Heartflow, INC. | $16.61 | 2024 | |
| Hologic Sales and Service, LLC | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elsayed Mohamed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.